In our experience with >250 HI patients/families, WES leads to a genetic diagnosis in 25–35 % of GJB2- and STRC-mutation-negative cases, with higher diagnostic rates achieved for individuals with an early (congenital or infant) onset of HL. This evidence concerns the gene GJB2 and Hodgkins lymphoma.